Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga68-Dolacga PET for Liver Reserve in Hepatic Carcinoma
NCT05007548Phase 2Completed
- Sponsor
- National Atomic Research Institute
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 dotatate in hepatocellular carcinoma (HCC), sponsored by National Atomic Research Institute. Started Dec 2021; status: completed.
02
Drugs
gallium ga 68 dotatate
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05007548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007548.